Unlock answers in myeloid-origin cancers with a targeted DNA panel
Identify key single nucleotide variants, insertions and deletions, copy number variations, and internal tandem duplications with targeted NGS of 37 core genes relevant for acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), and lymphoid malignancies research.
Detect confidently with Archer VARIANTPlex NGS Panels for DNA.
Learn how the Archer VARIANTPlex Core Myeloid panel can identify key genomic alterations for your research.
Request a consultationSpecifications | |
---|---|
Targeted genes | 37 |
Genomic alterations | SNVs, Indels, CNVs, ITDs |
Input DNA required* | ≥10 ng |
Recommended number of reads | 3 M |
Hands-on time | <3.5 hours |
Total library prep time | 1.5 day |
Platform compatibility | Illumina® |
Reagent format | Lyophilized or liquid |
Supported sample types | Blood, bone marrow, fresh frozen, BMMC, PBMC |
*Input mass requirements vary depending on type and quality. Unless the tumor cellularity and sample quality are high, 50 ng of FFPE-derived nucleic acid should be considered the minimum recommendation. If input is not limiting, 200 ng is recommended.
Customize this NGS panel by adding any of our functionally-tested designs or create a new panel that fits your exact requirements with Assay Marketplace.
Talk with our technical sales team. Learn how the Archer VARIANTPlex Core Myeloid panel can identify key genomic alterations for your research.
Request a consultationRUO23-2272_001